Skip to content

Clinical trials

Phase 3 Carcinoma, Hepatocellular trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 3 Country / region: Germany Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20091
20103
20122
20133
20141
20153
20173
20184
20194
20201
20211
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting6
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Bayer4
Bristol-Myers Squibb3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
Eli Lilly and Company2
Exelixis2
Abbott1
BeiGene1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular35
Liver Neoplasms9
Neoplasms6
Carcinoma5
Adenocarcinoma2
Digestive System Diseases2
Digestive System Neoplasms2
Liver Diseases2
Neoplasms by Histologic Type2
Neoplasms by Site2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.